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Abstract 
BID, a pro-apoptotic Bcl-2 family member, promotes cytochrome c release during apoptosis initiated 
by CD95L or TNF. Activation of caspase-8 in the latter pathways results in cleavage of BID, 
translocation of activated BID to mitochondria, followed by redistribution of cytochrome c to the 
cytosol. However, it is unclear whether BID participates in cytochrome c release in other (non-death 
receptor) cell death pathways. Here, we show that BID is cleaved in response to multiple death-
inducing stimuli (staurosporine, UV radiation, cycloheximide, etoposide). However BID cleavage in 
these contexts was blocked by Bcl-2, suggesting that proteolysis of BID occurred distal to cytochrome 
c release. Furthermore, addition of cytochrome c to Jurkat post-nuclear extracts triggered breakdown 
of BID at Asp-59 which was catalysed by caspase-3 rather than caspase-8. We provide evidence that 
caspase-3 catalysed cleavage of BID represents a feedback loop for the amplification of mitochondrial 
cytochrome c release during cytotoxic drug and UV radiation-induced apoptosis. 
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Introduction 
Apoptosis is a mode of cell death that is involved in situations where elimination of specific cells in 
necessary for the development, maintenance, and survival of multicellular organisms.1 In recent years, 
evidence has accumulated to argue that apoptosis is orchestrated by a panoply of cysteine proteases - 
the caspases - that cooperate to dismantle the cell upon receipt of a death-inducing stimulus.2,3,4 
Stimuli that trigger apoptosis are diverse and appear to engage the cell death machinery in a variety of 
ways.5 However, evidence is emerging to suggest that the signals generated by numerous death-
promoting agents all converge at some point on mitochondria and trigger release of cytochrome c, as 
well as other factors such as apoptosis inducing factor (AIF), from this organelle.6,7,8,9,10,11 Thus, 
although pro-apoptotic signals that provoke cytochrome c release from mitochondria may do so by a 
variety of means, events that take place distal to this step may be relatively conserved. This view is 
supported by the observation that the Bcl-2 protein can efficiently block apoptosis in response to 
diverse death-promoting signals, possibly due to its ability to regulate the cytochrome c release 
checkpoint in the cell death pathway.6,7 Whereas cell death-associated events that take place upstream 
of this checkpoint may be stimulus-specific, downstream events are likely to be stimulus-independent 
and may be largely dictated by the interaction between cytochrome c and its cytosolic target, Apaf-
1.12,13,14,15 
The importance of the cytochrome c/Apaf-1 arm of the cell death pathway is underscored by the 
phenotype of Apaf-1 knockout mice, in which large numbers of redundant cells accumulate during 
foetal development - resulting in embryonic lethality.13,14 Despite the ubiquity of cytochrome c release 
in apoptosis, the mechanisms that regulate this event are relatively poorly understood.9 Recent studies 
have presented data to argue that BID, a death promoting member of the Bcl-2 family, promotes 
cytochrome c release in the Fas/CD95- and TNF-initiated cell death pathways.16,17,18,19,20 In these 
contexts, receptor engagement results in early activation of caspase-8 through proximity-induced 
transprocessing that is facilitated by the FADD and TRADD adaptor proteins. Active caspase-8 
cleaves cytosolic BID, resulting in translocation of the C-terminal portion of BID to the mitochondria, 
followed by integration into the outer mitochondrial membrane.16,17,18,19 Insertion of BID into the 
mitochondrial membrane was found to be a potent instigator of cytochrome c release from 
mitochondria, via an as yet unknown mechanism. Significantly, whereas Bcl-2 and Bcl-x did not 
prevent cleavage of BID in the context of death receptor-initiated apoptosis, these proteins were 
capable of blocking the subsequent release of cytochrome c from mitochondria, in agreement with 
their perceived role as regulators of mitochondrial integrity.16,17,18,19 
Mitochondrial cytochrome c release in non-death receptor pathways is less well understood. Recent 
data suggests that the pro-apoptotic Bcl-2 family proteins Bax and Bak may promote cytochrome c 
efflux, possibly due to their ability to bind and regulate components of the multiprotein permeability 
transition pore complex.21,22,23,24,25 The role of BID, if any, in cytochrome c release in the context of 
non-death receptor-induced cell deaths (cytotoxic drugs, radiation) remains unknown. Here, we show 
that BID is cleaved in response to divergent, non-death receptor associated, death stimuli 
(staurosporine, UV radiation, cycloheximide, etoposide), suggesting that this may contribute to the 
cytochrome c release that is seen during apoptosis induced by these agents. However, BID cleavage in 
these contexts was found to occur downstream of the point of Bcl-2 action, suggesting that this event 
occurred distal to cytochrome c release into the cytosol. In line with these observations, addition of 
cytochrome c to cell-free extracts of Jurkat cells triggered BID cleavage which was catalysed by 
caspase-3 as opposed to caspase-8. Immunodepletion of caspase-3 from extracts abolished 
cytochrome c-inducible BID cleavage. Similarly, cytochrome c-initiated BID cleavage was also 
absent in extracts derived from MCF-7 cells that are naturally devoid of caspase-3.26 Addition of 
cytochrome c to cell extracts containing healthy mitochondria provoked cytochrome c release from 
these mitochondria. These data suggest that cytochrome c release from mitochondria can be amplified 
through a caspase-3/BID feedback loop, irrespective of the initial trigger for cytochrome c 
redistribution to the cytosol. 
 
Results 
BID is cleaved during apoptosis initiated by diverse stimuli 
Previous studies have established that apoptosis-promoting stimuli such as staurosporine and UV 
radiation trigger release of cytochrome c from mitochondria and that this release can be regulated by 
Bcl-2.6,7,29 Recent studies have implicated BID in the cytochrome c release that is seen during FasL 
and TNF-induced apoptosis.16,17,18,19,20 However, it is unclear whether BID plays a similar role in non-
death receptor-mediated cell deaths. To address this question, we induced apoptosis in Jurkat T 
lymphoblastoid cells using a range of pro-apoptotic stimuli and monitored BID protein levels as cells 
entered apoptosis. 
Figure 1 shows that levels of intact BID dramatically decreased after exposure to staurosporine, UV 
radiation, cycloheximide and etoposide suggesting that BID is cleaved in non-death receptor cell 
death contexts. Interestingly, we consistently observed much more significant decreases in the levels 
of intact BID during apoptosis induced by non-death receptor stimuli, when compared with the 
decreases seen in response to Fas ligation, despite the fact that populations with similar numbers of 
apoptotic cells were compared. Figure 1 also illustrates that there was little correlation between the 
extent of BID cleavage and the degree of caspase-8 activation in the same samples, as assessed by the 
appearance of processed forms of caspase-8, suggesting that BID cleavage in the non-death receptor 
pathways may be mediated by another caspase. 
 
Staurosporine and UV-induced BID cleavage is blocked by Bcl-2 
It has been demonstrated that cleavage of BID in the context of Fas- or TNF-induced apoptosis is not 
blocked by Bcl-2 or Bcl-x, rather, these death repressor proteins block BID-induced release of 
cytochrome c.16,17,18 This implies that cleavage of BID occurs upstream of the point of Bcl-2 action in 
death receptor pathways. To ask whether this was also true in the context of non-death receptor 
initiated cell deaths, we examined BID cleavage in CEMvector versus CEMbcl-2 cells that were induced 
to undergo apoptosis by exposure to staurosporine or UV radiation. 
As illustrated in Figure 2, CEMbcl-2 cells were resistant to both staurosporine- and UV-radiation 
induced apoptosis, as previously reported.30,31 Both stimuli triggered multiple caspase activation 
events in CEMvector cells but all of these activation events were very substantially inhibited in CEMbcl-2 
cells, suggesting that these caspases are activated downstream of the point of Bcl-2 action. In line 
with these observations, multiple caspase substrate cleavage events (fodrin, PARP, U1snRNP, lamin 
B, topoisomerase I) were also blocked in cells overexpressing Bcl-2 (data not shown). Surprisingly, 
UV- and staurosporine-induced cleavage of BID was also completely blocked in CEMbcl-2 cells, 
suggesting that BID cleavage occurs downstream of the point of Bcl-2 action in these pathways 
(Figure 2B). This contrasts sharply with observations made in the context of Fas and TNF-initiated 
apoptosis where Bcl-2 and Bcl-x failed to block cleavage of BID, but blocked its downstream effects 
by antagonising BID-mediated release of cytochrome c from mitochondria.16,17,18 
   
Cytochrome c triggers cleavage of BID in cell-free extracts 
Because staurosporine- and UV-initiated BID cleavage was completely repressed by Bcl-2, this 
suggested that cleavage of BID in these contexts was occurring downstream of the mitochondrial 
event(s) that Bcl-2 regulates. Bcl-2 has been shown to block the release of mitochondrial cytochrome 
c in a variety of cell death contexts - including death initiated by staurosporine and UV radiation6,7 - 
thereby attenuating the Apaf-1-mediated activation of caspase-9 and the subsequent caspase 
cascade.12,15,32,33 Thus, we asked whether BID was cleaved downstream of the point of cytochrome c 
release, as the Bcl-2 data would predict. 
To explore this question, we utilised a cell-free system based on Jurkat post-nuclear extracts that can 
support cytochrome c-initiated apoptotic events, such as caspase activation, cleavage of caspase 
substrates and condensation of nuclei.15 Figure 3 illustrates that introduction of cytochrome c and 
dATP into these extracts initiated multiple caspase activation events, as previously reported.15 
Significantly, cytochrome c also triggered cleavage of BID to yield a cleavage product of ~15 kDa, 
confirming that BID cleavage can take place upon entry of cytochrome c into the cytosol (Figure 3B). 
In the cell death pathway that is engaged by the Fas/CD95 and TNF receptors, BID has been shown to 
undergo caspase-8-mediated proteolytic cleavage at Asp-59 to liberate a 15 kDa C-terminal cleavage 
product that translocates to the mitochondria and triggers release of cytochrome c.16,17,18 To explore 
whether BID was cleaved at a similar site in response to cytochrome c we used a D59A mutant of 
BID that has been shown to resist caspase-8-mediated cleavage.17 Figure 3C illustrates that whereas 
wild-type BID was efficiently cleaved upon introduction of cytochrome c and dATP into Jurkat 
extracts, the D59A mutant was not, suggesting that cleavage occurred at this site. 
 
Cytochrome c-initiated cleavage of BID is catalysed by caspase-3 
Cytochrome c triggers multiple caspase activation events due to its ability to promote activation of 
caspase-9 via Apaf-1.15,32,33,34 Upon activation, caspase-9 then provokes a hierarchical caspase cascade 
resulting in the activation of caspases -3, -7, -2, -6, -8, and -10.15 To determine which of the caspases 
were responsible for the cleavage of BID in the cascade initiated by cytochrome c, we used a 
combination of approaches. First, we explored the effects of three different caspase inhibitory 
peptides (z-VAD-fmk, VEID-CMK, DEVD-CHO) on cytochrome c-initiated BID cleavage (Figure 
4A). These experiments suggested that a caspase-3-like activity was required for the cleavage of BID 
in this context. 
To test this further, we depleted caspase-3, caspase-6 or caspase-7 from Jurkat extracts, using 
antibodies specific to each of these caspases, and explored whether the extracts could still support 
cytochrome c-initiated BID cleavage. Figure 4B,C illustrates that, whereas depletion of caspase-6 or 
caspase-7 had no significant effect, extracts devoid of caspase-3 failed to support cleavage of BID. As 
further confirmation of the role of caspase-3 as the caspase responsible for the cleavage of BID in the 
cytochrome c pathway, we used extracts of MCF-7 cells that are devoid of caspase-3 due to a deletion 
in exon 3 of the CASP3 gene.26 As previously reported, cytochrome c was able to initiate processing 
of caspase-9 and caspase-7 in MCF-7 extracts, but failed to support processing of caspase-6, as this 
event requires caspase-3.15 In line with these observations, MCF-7 extracts also failed to support 
cytochrome c-induced BID cleavage. Taken together, these data strongly implicate caspase-3 as the 
caspase responsible for the cleavage of BID downstream of cytochrome c release. 
   
Caspase-3 cleaves BID at Asp-59 and promotes cytochrome c release from mitochondria 
To confirm that caspase-3 directly cleaves BID and to map the cleavage site, we exposed wild-type 
BID, as well as the D59A mutant, to recombinant caspase-3 or caspase-8. Figure 5 illustrates that 
recombinant caspase-3 could efficiently cleave wild-type BID over a wide range of concentrations, 
but the D59A mutant remained intact under the same conditions. 
Caspase-8 has been shown to be capable of promoting cytochrome c release from mitochondria due to 
its ability to catalyse the cleavage of BID, the C-terminal portion of which then integrates into the 
outer mitochondrial membrane.16,17,18,19 Because caspase-3 can cleave BID at an identical site, this 
suggested that caspase-3 should also be capable of triggering cytochrome c release. Thus, we exposed 
purified mouse liver mitochondria to similar concentrations of recombinant caspase-3 or caspase-8 in 
the presence or absence of Jurkat extract as a source of BID. These experiments revealed that both 
caspases could promote cytochrome c release to a similar extent, but only in the presence of BID-
containing cytosol (Figure 5B). 
 
Cytochrome c release triggers a feedback amplification loop that promotes release of further 
cytochrome c 
Our observations that cytochrome c can trigger cleavage of BID in a caspase-3-dependent manner 
suggest that cytochrome c should be capable of driving a feedback loop (via BID) that results in 
further release of cytochrome c from intact mitochondria. To explore this possibility, we exposed 
purified mouse liver mitochondria to cytochrome c under conditions where caspase-3 activation and 
BID cleavage occurred. Figure 6A shows that addition of cytochrome c to Jurkat extracts containing 
freshly purified mitochondria resulted in the release of cytochrome c from these mitochondria in 
parallel with the activation of caspase-3. Mitochondria incubated for the same duration in the presence 
of extract alone failed to release cytochrome c (Figure 6A). 
Whereas FasL and TNF-induced cytochrome c release have been reported to be caspase-
dependent,16,17,18,35 the release of cytochrome c in several other contexts (including staurosporine and 
UV-induced apoptosis) has been found to be at least partially caspase-independent.11,29 This suggests 
that caspase-cleaved BID is not initially involved in provoking the cytochrome c release seen in these 
contexts. However, it remains possible that upon release of cytochrome c via a caspase-independent 
mechanism, further cytochrome release is achieved via a caspase-3/BID-dependent feedback loop. 
To explore this possibility, we examined the effect of the broad spectrum caspase inhibitor, z-VAD-
fmk, on staurosporine- and UV-induced cytochrome c release in Jurkat cells. These experiments 
revealed that a substantial portion of the cytochrome c release seen in response to staurosporine and 
UV radiation was attenuated in the presence of z-VAD-fmk, providing evidence that a caspase-
dependent feedback loop may be operative in these death pathways (Figure 6B). Thus, cytochrome c-
initiated cleavage of BID is likely to represent a means of amplifying cytochrome c release in cell 
death pathways where the initial cytochrome c redistribution to the cytosol occurs in a caspase-
independent manner. 
 
Discussion 
BID has been implicated as the instigator of mitochondrial cytochrome c release early in the 
CD95/Fas and TNF pathways.16,17,18,19,20,35 Whereas full-length BID is a relatively poor inducer of 
cytochrome c release, the C-terminal portion of BID that is generated upon cleavage by caspase-8 is 
very potent in this regard. Here we have shown that engagement of the cytochrome c/Apaf-1 pathway 
also results in BID cleavage. In contrast with the Fas and TNF pathways, BID proteolysis in this 
setting was mediated by caspase-3 and was blocked by overexpression of Bcl-2. In line with these 
observations, caspase-3 was found to be capable of promoting cytochrome c release from 
mitochondria, which correlated with its ability to cleave BID. These data suggest that the release of 
cytochrome c from mitochondria can drive an amplification loop that promotes further cytochrome c 
release and consequent caspase activation, thereby explosively amplifying the death signal. This loop 
may be particularly important in situations where the initial, caspase-independent, release of 
cytochrome c is relatively minor. 
Evidence is accumulating to indicate that release of cytochrome c from the mitochondrial 
intermembrane space during apoptosis is a highly regulated event.9,23,25,36 Entry of cytochrome c into 
the cytosol has severe consequences for the cell on two levels. On one level, the loss of this key 
component of the mitochondrial electron transport chain is likely to result in the disruption of ATP 
synthesis which will lead to cell death, regardless of whether the phenotype of this death is apoptosis 
or necrosis. On another level, cytochrome c can directly drive caspase-dependent death (apoptosis) 
due to its ability to act as a co-factor for the CED-4 homologue, Apaf-1.12 Binding of cytochrome c to 
Apaf-1, in association with dATP or ATP, results in Apaf-1-mediated activation of caspase-9, 
probably via a clustering mechanism.33,37,38,39,40 Caspase-9 then propagates a caspase cascade by 
directly processing caspases -3 and -7.15,33 The latter caspases then activate other caspases as well as 
cleaving structural and regulatory proteins. All of these proteolytic cleavage events ultimately result 
in the full-blown apoptotic phenotype which triggers recognition and removal of the dying cell by 
phagocytes. 
Whereas BID is thought to be the initial trigger for cytochrome c release in the Fas and TNFR death 
receptor pathways, the mechanism(s) by which cytotoxic drugs and other cellular stresses provoke the 
initial release of cytochrome c from mitochondria is unclear. A number of studies have implicated 
Bax as a trigger for (caspase-independent) mitochondrial cytochrome c release during 
apoptosis.21,22,23,24,25,41,42 Irrespective of the initial means of triggering cytochrome c redistribution to 
the cytosol, the cleavage of BID downstream of this point introduces the possibility of a caspase-
dependent feedback amplification loop, where caspase-3-cleaved BID is able to act back on the 
mitochondria causing further cytochrome c release - thereby perpetuating and amplifying the caspase 
cascade (Figure 7). In a scenario where there is an initial release of a small amount of cytochrome c, 
this may be sufficient to allow limited Apaf-1-mediated activation of caspase-9, followed by caspase-
3 activation as a consequence. Cleavage of BID upon activation of caspase-3 may provoke a much 
more significant (caspase-dependent) release of cytochrome c. This scheme may provide an 
explanation for the ability of Bcl-2 to inhibit apoptosis in response to microinjection of cytochrome c 
into the cytosol, as Bcl-2 might simply have blocked a cytochrome c-driven feedback loop.43,44 
Interestingly, MCF-7 cells (that lack caspase-3) are refractory to the effects of microinjected 
cytochrome c,45 but introduction of caspase-3 restored susceptibility to this treatment, possibly as a 
result of restoration of the feedback loop.45 
Because caspase-3 is responsible for cleavage of many of the structural and regulatory proteins that 
are broken down during apoptosis,46,47 it is generally believed that caspase-3 is a downstream effector 
that exerts its effects during the final phase of death. However, the dramatic failure to delete 
numerous cells in the CNS of casp-3-/- mice suggests that caspase-3 plays a more upstream role in 
deciding the fate of certain cell populations (or the response to certain stimuli). In the latter cell types, 
it is plausible that the absence of caspase-3 alters the threshold at which cells engage their death 
machinery and cells lacking this caspase fail to die as a consequence. 
In summary, we have shown that, in addition to its ability to instigate cytochrome c release in death 
receptor-mediated apoptosis, BID is also cleaved and activated as a consequence of cytochrome c 
release. In these circumstances the activated BID is able to participate in a feedback loop which may 
act to sustain and amplify the death signal. This feedback loop is regulated by Bcl-2, which prevents 
the cleavage of BID in response to cytochrome c release. This study provides a further insight into the 
control points at which death regulating molecules such as Bcl-2 can act, and also highlights the 
essential contribution of caspase-3 to the correct execution of the cell. 
 
Materials & Methods 
Materials 
Anti-caspase-3 and anti-caspase-9 polyclonal antibodies were kindly provided by Drs. J Reed and D 
Green, respectively; anti-caspase-3, anti-caspase-7 and anti-gelsolin mouse monoclonal antibodies 
were purchased from Transduction Laboratories (Lexington, KY, USA); anti-caspase-8 antibody was 
purchased from Pharmingen (San Diego, CA, USA); purified rabbit polyclonal anti-caspase-6 
antibody was purchased from Upstate Biotechnology (Lake Placid, NY, USA); anti-BID rat 
polyclonal antibody was kindly provided by Dr. J Yuan; anti-human/mouse BID goat polyclonal 
antibody was purchased from R&D Systems (Abingdon, UK); anti-BID rabbit polyclonal antibody 
was kindly provided by Dr. X Wang; anti-cytochrome c rabbit polyclonal antibody was kindly 
provided by Dr. D Newmeyer; anti-β-actin and anti-α-tubulin antibodies were purchased from ICN 
(Costa Mesa, CA, USA). Anti-Fas mAb clone CH-11 was purchased from Upstate Biotechnology. 
Ac-DEVD-CHO and Z-VAD-FMK peptides were purchased from BACHEM Bioscience (King of 
Prussia, PA, USA); VEID-CMK was purchased from Clontech (Palo Alto, CA, USA). Staurosporine, 
etoposide, cycloheximide and bovine heart cytochrome c were purchased from Sigma Chemical Co. 
(Poole, UK), and dATP was purchased from Boehringer Mannheim (Lewes, UK). Bacterially-
expressed recombinant caspase-3 and caspase-8, kindly provided by Dr. G Salvesen, were produced 
and purified as described previously.27 
Cell culture and induction of apoptosis 
Jurkat, CEM and MCF-7 cells were cultured in RPMI 1640 (Gibco, Paisley, UK) with 5% foetal calf-
serum (Sigma). To induce apoptosis, Jurkat or CEM cells were suspended at 1x106 cells/ml, and 
incubated either alone or in the presence of anti-Fas CH-11 IgM (100 ng/ml), staurosporine (500 nM), 
cycloheximide (10 μM) or etoposide (10 μM), or exposed to UV radiation for 15 min. Where 
appropriate, the cells were pre-incubated for 1 h with z-VAD-fmk (50 μM). 
Preparation of cell lysates for analysis by SDS-PAGE 
Following incubation the cells were pelleted and washed twice in ice-cold phosphate buffered saline 
(PBS) PH 7.2, then resuspended at 4x107/ml in resuspension buffer (100 mM NaCl, 10 mM Tris pH 
7.6, 1 mM EDTA). The cells were diluted to 2x107/ml in 2xSDS loading buffer and the cellular 
proteins separated by SDS polyacrylamide gel electrophoresis at 106 cells/lane. 
Preparation of cell-free extracts 
Post-nuclear extracts were generated from Jurkat T lymphoblastoid cells or MCF-7 cells essentially as 
previously described.15 Briefly, cells (2-5x108) were pelleted and washed x2 with PBS, pH 7.2. Cells 
were then transferred to a 2 ml Dounce-type homogenizer, were pelleted, and two volumes of ice-cold 
cell extract buffer (CEB) was added to the volume of the packed cell pellet (CEB; 20 mM HEPES-
KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 100 μM 
phenylmethylsulphonyl fluoride, 10 μg/ml leupeptin, 2 μg/ml aprotinin). Cells were allowed to swell 
under the hypotonic conditions for 15 min on ice, then disrupted with ~40 strokes of a B-type pestle. 
Lysis was confirmed by examination of a small aliquot of the suspension under a light microscope. 
Lysates were then transferred to eppendorf tubes and were centrifuged at 15 000xg for 15 min at 4°C 
to generate post-nuclear extracts. The supernatant was removed while taking care to avoid the nuclear 
and mitochondrial pellet. Supernatants were then frozen in aliquots at -70°C until required. 
Depletion of caspases from cell extracts 
Caspase-3, -6, or -7 were depleted from cell extracts using protein A/G-agarose-immobilized 
antibodies specific for these proteins, as follows. Aliquots (40 μl) of protein A/G agarose (Santa Cruz, 
CA, USA) were pre-coated with 5 μg of appropriate anti-caspase antibodies, or a control antibody 
(mouse or rabbit purified IgG; Sigma, UK), by incubation in a total volume of 300 μl in PBS, pH 7.2, 
for 3 h at 4°C under rotation. Antibody coated beads were washed three times in PBS before addition 
to Jurkat cell extracts (100 μl). Extracts were then incubated overnight under constant rotation at 4°C. 
Beads were removed from the extracts by centrifugation. Depletion of specific caspases from the 
extracts was confirmed by Western blotting, as previously described.15 
Preparation of mouse liver mitochondria 
Mitochondria were prepared fresh on the day of use and the entire procedure was undertaken on ice. 
Mouse livers (4-5 grams) were placed in mitochondria buffer (MTB); 250 mM mannitol, 1 mM 
EDTA, 5 mM KH2PO4, 5 mM MOPS/KOH pH 7.4) and chopped into fine pieces. Liver fragments 
were then washed 2-3 times in MTB to remove residual blood, followed by homogenization with 5-10 
strokes using a tight fitting teflon pestle. The homogenate was centrifuged at 500xg for 10 min to 
pellet unbroken cells and debris, and the supernatant decanted into a fresh centrifuge tube. 
Mitochondria were pelleted by centrifugation for a further 7 min at 12 500xg. The mitochondrial 
pellet was resuspended in MTB, taking care to avoid any residual cells at the bottom of the tube, 
followed by pelleting again. Mitochondria were brought to a final volume of 1 ml in mitochondria 
storage buffer (MSB; 400 mM mannitol, 10 mM KH2PO4, 50 mM Tris pH 7.2, 5 mg/ml bovine serum 
albumen, 100 μM phenylmethylsulphonyl fluoride, 10 μg/ml leupeptin, 2 μg/ml aprotinin) and 
maintained on ice until required. 
Coupled in vitro transcription/translation 
35S-methionine-labelled proteins were in vitro transcribed and translated using the TNT kit (Promega, 
Southampton, UK), as previously described.15,28 Typically, 1 μg of plasmid was used in a 50 μl 
transcription/translation reaction containing 2 μl of translation grade [35S]-methionine (1000 μCi/ml; 
NEN Life Sciences, Hounslow, UK). 
Cell-free reactions 
Cell-free reactions were typically set up in 10 or 20 l reaction volumes. For 20 μl scale reactions, 10 
μl of cell extract (~5 mg/ml) was brought to a final volume of 20 μl in CEB, with or without additions 
solubilized in the same buffer. Cell-free apoptosis was typically induced by addition of bovine heart 
cytochrome c and dATP to a final concentrations of 50 μg/ml and 1 mM, respectively. Extracts were 
then incubated at 37°C for periods of up to 3 h. When isolated mitochondria were included in the 
reaction, CEB was supplemented with mannitol (220 mM) and sucrose (68 mM). 
Assessment of cytochrome c release in intact cells 
To assess mitochondrial cytochrome c redistribution in intact cells, the cells were washed twice in 
PBS and resuspended in 100 μl MTB and broken open by centrifugation at 20 000xg for 15 min at 
4°C. The pellet was resuspended in the same supernatant and centrifuged again under the same 
conditions. Supernatants were then collected and frozen until required for analysis. In some 
experiments a different procedure was used. Here, the cells were transferred to a 2 ml Dounce 
homogeniser (after washing twice in PBS, pH 7.2), and were resuspended in CEB supplemented with 
220 mM mannitol and 68 mM sucrose. After incubation on ice for 20 min, the cells were lysed by ~50 
strokes of the pestle and the debris pelleted by centrifugation at 14 000xg for 15 min at 4°C. The 
supernatants were collected and normalised for protein content, then frozen until required. 
SDS-PAGE and Western blot analysis 
Proteins were subjected to standard SDS-polyacrylamide gel electrophoresis at 60-70 V and were 
transferred onto 0.45 μm PVDF membranes (Gelman, Northampton, UK) or 0.2 μm nitrocellulose 
membranes (Whatman, Maidstone, UK) overnight at 40-50 mA, followed by probing for various 
proteins using the antibodies described under Materials and Methods. Bound antibodies were detected 
using appropriate peroxidase-coupled secondary antibodies (Amerhsam Pharmacia Biotech, Little 
Chalfont, UK) followed by detection using the Supersignal chemiluminescence system (Pierce, 
Chester, UK), all as previously described.15,28 
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Figure 1 BID cleavage occurs during apoptosis induced by diverse stimuli. (A) Jurkat cells were treated either 
with anti-Fas IgM mAb (100 ng/ml), staurosporine (500 nM), cycloheximide (10 μM), etoposide (10 μM), UV 
radiation (20 min), or were left untreated, as indicated. Cells were then incubated for either 8 h (staurosporine) 
or 16 h (all other treatments), prior to preparation of cell lysates for Western blotting. Blots were probed for the 
indicated proteins using appropriate antibodies as described under Materials and Methods. Equal protein 
loadings were confirmed by probing for actin. Where cleavage products were detectable, these are indicated by 
arrows. (B) Jurkat cells were incubated in the presence of 500 nM staurosporine and cell lysates were prepared 
at the indicated times. Cell lysates were Western blotted followed by probing for the indicated proteins 
   
  
Figure 2 Bcl-2 blocks staurosporine- and UV-induced apoptosis upstream of caspase activation and BID 
breakdown. (A) CEM cells, stably transfected with either Bcl-2 or vector plasmid, were exposed to 500 nM 
staurosporine (STS), or UV radiation (20 min), followed by incubation for 6 h at 37°C. Apoptosis was 
quantitated by staining cells with annexin V-FITC, which detects phosphatidylserine externalisation, followed 
by flow cytometric analysis. Each data point represents counts made on 10 000 cells and results are 
representative of five separate experiments. (B) Cell lysates, prepared from cells treated as in (A), were blotted 
for the indicated proteins. Where cleavage products were detectable, these are indicated by arrows. Results are 
representative of five separate experiments 
   
  
Figure 3 Cytochrome c initiates BID cleavage in cell-free extracts. (A) Time course of cytochrome c/dATP-
induced caspase activation and gelsolin cleavage in Jurkat cell-free extracts. Cell-free extracts were prepared 
and reactions were set up as described under Materials and Methods. Reactions were incubated at 37°C in the 
presence or absence of cytochrome c (50 μg/ml) and dATP (1 mM), as shown. (B) Time course of BID cleavage 
under conditions identical to those used in (A). BID was detected by Western blotting. (C) Cleavage of 35S-
labelled BID and 35S-labelled BID D59A mutant, prepared by in vitro transcription and translation, under 
similar conditions to those used in (A). Intact BID and BID cleavage products were visualised by fluorography. 
Results are representative of three separate experiments 
   
  
Figure 4 Cytochrome c-initiated processing of BID requires caspase-3. (A) Cytochrome c-induced BID 
breakdown requires a DEVD-inhibitable activity. Jurkat extracts, containing 35S-labelled BID, were incubated 
for 2 h with cytochrome c (50 μg/ml) and dATP (1 mM), either alone, or in the presence of Z-VAD-FMK, 
VEID-CMK or DEVD-CHO (100, 10 and 1 μM), as indicated. Proteins were then separated by SDS-PAGE and 
visualised by fluorography. (B) Caspase-3, but not caspases -6, or -7, is required for cytochrome c-initiated BID 
cleavage. Jurkat extracts were either mock-depleted, or were immunodepleted with antibodies specific for 
caspases -3, -6 or -7, and then incubated for 2 h with or without cytochrome c/dATP, as shown. Levels of intact 
BID were then assessed by Western blot. (C) Caspase-3 is required for the breakdown of 35S-labelled BID in 
vitro. Mock-depleted or caspase-3-depleted Jurkat cell-free extracts were incubated for 2 h in the presence or 
absence of cytochrome c/dATP, as shown. Extracts were supplemented with either 35S-labelled caspase-7 or 35S-
labelled BID, as indicated. (D) BID is not cleaved in caspase-3-deficient MCF-7 cell extracts in response to 
cytochrome c. Extracts were incubated for 2 h in the presence or absence of cytochrome c/dATP, as indicated. 
Breakdown of 35S-labelled BID, and processing of 35S-labelled caspases -6 and -7 was determined by SDS-
PAGE followed by fluorography. Caspase-9 processing was determined by Western blot 
   
  
Figure 5 Caspase-3 cleaves BID at a site identical to that cleaved by caspase-8 and can also promote 
cytochrome c release from mitochondria. (A) 35S-labelled BID wild-type (WT), or 35S-labelled BID D59A 
mutant, were incubated for 2 h with the indicated concentrations of purified recombinant caspase-3 or caspase-8. 
Proteins were then separated by SDS-PAGE followed by fluorographic detection of radiolabeled proteins. 
Results are representative of two separate experiments. (B) Caspase-8 and caspase-3 both induced the release of 
mitochondrial cytochrome c in the presence of Jurkat cell extract. Purified mouse liver mitochondria were 
incubated for 60 min with the indicated volumes of Jurkat extract (~5 μg/μl) in a final reaction volume of 20 μl, 
either alone (buffer), or in the presence of 25 ng of purified recombinant caspase-3 or caspase-8. Mitochondria 
were then pelleted by centrifugation at 12 500xg and the supernatants analyzed for released cytochrome c by 
SDS-PAGE and Western blotting 
   
  
Figure 6 Evidence for a feedback loop that amplifies cytochrome c release during apoptosis. (A) Cytochrome c 
can induce further cytochrome c release from isolated mitochondria. Purified mouse liver mitochondria were 
incubated with Jurkat extract alone (lane 1), or with Jurkat extract containing cytochrome c (6.25 μg/ml) and 
dATP (1 mM) (lanes 3-8) for the time periods indicated. The amount of cytochrome c that represents the input 
(background) level is shown in lane 2. Following incubation for the indicated periods of time, the mitochondria 
were pelleted (12 500xg, 7 min) and the supernatants were analyzed for released cytochrome c or caspase-3 
processing, by Western blot, as indicated. (B) Caspase activity is required for maximal cytochrome release 
during staurosporine- and UV-induced apoptosis. Jurkat cells were either treated with staurosporine (500 nM), 
or were UV-irradiated (15 min), in the presence or absence of the broad-spectrum caspase inhibitor, Z-VAD-
FMK (50 μM). After incubation for 5 h, cells were lysed and mitochondria were pelleted as described under 
Materials and Methods. Supernatants were then analyzed by SDS-PAGE followed by Western blotting for the 
detection of the indicated proteins. Where z-VAD-fmk was used, cells were pre-incubated with this peptide for 
1 h prior to the initiation of apoptosis 
  
  
Figure 7 Schematic representation of caspase-3/BID-mediated amplification of cytochrome c release 
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